Taj Pharma receives GMP certificate from Ivory Coast Health Ministry

Taj Pharmaceuticals has received the certificate of Good Manufacturing Practices (GMP) from Ivory Coast’s health ministry for exporting pharmaceutical products in the region. This approval is as per the format prescribed by World Health Organization (WHO). The approval has been granted for a period of 5 years initially.

Announcing this Mr.Shantanu Kumar Singh, Executive Director, Taj Pharmaceuticals said, “Ivory Coast had conducted a detailed inspection of the manufacturing facilities at Taj Pharma’s Sarigam, Vapi plant in December 2022 and found them to be compliant of all quality standard requirements as per Ivory Coast FDA and WHO-GMP norms.” With this certificate Ivory Coast market would be open for Taj Pharmaceuticals making healthy contribution to its export sales from the area, added Mr. Singh.

Taj Pharma is eyeing to expand its international business in a big way. The firm is planning to invest $35 million in commissioning a new manufacturing facility in South Africa. The above certification will help Taj Pharma to tap the large African market, out of which Kenya and Nigeria being the most lucrative market.

Taj Pharma has already filed 65 product dossiers under the various therapeutic categories like antibiotics, antifungals, antimalarials and PPI formulations for registration in the country out of which 11 products have already been registered. The products will be exported to Senegal, Cameroon, Gabon, Nigeria, Angola, Tanzania, Kenya, Rwanda, Libya, Madagascar, Congo (DRC), Burkina Faso, and Benin along with Ivory Coast in the form of tablets, capsules, dry injections, and liquids.

Taj Pharma has tied up with leading distributors and also filled tenders of Government bodies to export its products in other African regions as well.